Hoth, Zura top healthcare gainers; HTG Molecular, NovoCure lead losers' pack

Jun. 06, 2023 10:05 AM ETTHMO, BHC, HQY, NVRO, HTGM, NVCR, HOTH, PBLA, TCRX, ZURABy: Ravikash, SA News Editor

Gainers: Hoth Therapeutics (HOTH) +114%. Zura Bio (ZURA) +15%. TScan Therapeutics (TCRX) +12%. HealthEquity (HQY) +11%. ThermoGenesis (THMO) +7%.
Losers: HTG Molecular Diagnostics (HTGM) -38%. NovoCure (NVCR) -27%. Nevro (NVRO) -18%. Bausch Health Companies (BHC) -10%. Panbela Therapeutics (PBLA) -8%.
S&P 500 Healthcare sector is currently down -0.43% to 1,515.49. Health Care Equipment & Services is down -0.81% and Pharmaceuticals, Biotechnology & Life Sciences are down -0.14%.